Overview
This will be a dynamic and insightful panel discussion featuring Editor-in-Chiefs from leading chronic pain and neuromodulation journals, with a plan to delve into the critical aspects of advancing research and manuscript preparation in this rapidly evolving field. Our distinguished panel will tackle pivotal topics such as the vision for future research in neuromodulation, strategies for crafting impactful manuscripts, and the common pitfalls that can hinder a successful submission.
Further, this panel will address burning questions that authors often face, including how to navigate the editorial review process effectively and the importance of revisions in enhancing manuscript quality. In addition, the session will explore collaborative initiatives between journals, emphasizing shared goals that could collectively propel the field forward, such as through the development of multisociety guidelines. Attendees will gain valuable insights on assessing the suitability of a journal for their work and learning about the challenges and benefits posed by the abundance of pain journals. Our goal is to spark a thought-provoking discussion on the need for consolidation and high-quality evidence within the field.
Target Audience
Engineer, Executive, Fellow, Medical student, Neurosurgeon, Neurologist, Physician, Pain Medicine Physician, Physical Medicine and Rehab Physician, Researcher, Resident, Scientist
Learning Objectives
1. To discuss future goals and priorities among premier pain and neuromodulation journals.
2. To discuss opportunities for collaboration and consolidation between premier pain and neuromodulation journals, while also discussing the advantages and disadvantages of having an abundance of pain journals.
3. To describe the steps in identifying the right journal for submission, approach to impactful revisions, and avoiding biggest pitfalls that lead to rejection.
Faculty
Ryan D'Souza, MD; Nasir Hussain, MD, MSc; Robert Hurley, MD, PhD; Robert Levy, MD, PhD; Michael Schatman, PhD; Christopher Gilligan, MD; Pedro Emanuel Rocha Flores, PhD; Disa Sullivan; and Jason Pope, MD
Disclosures
Any faculty member not on the disclosure list has reported nothing to disclose.
Ryan D’Souza, MD | Planner and Speaker
Nevro: Contracted Research (Ongoing)|Saol Therapeutics: Contracted Research (Ongoing)
Christopher Gilligan, MD | Speaker
Biotronik: Consulting Fees (Ongoing)|Iliad Lifesciences: Consulting Fees (Ongoing)|Mainstay Medical: Consulting Fees (Ongoing)|Mainstay Medical: Stock Options (Ongoing)|Persica: Consulting Fees (Ongoing)|Saluda Medical: Consulting Fees (Ongoing)
Robert Hurley, MD, PhD | Speaker
Nevro: Contracted Research (Ongoing)|NIH/NIDA: Collaborative grant (U24) (Ongoing)
Robert Levy, MD, PhD | Speaker
Abbott/St. Jude Medical: Uncompensated Consultant (Ongoing)|Biotronik: Uncompensated Consultant (Ongoing)|Mainstay Medical: Uncompensated Consultant (Ongoing)|Nalu Medical: Uncompensated Consultant (Ongoing)|Nalu Medical: Stock Options (Ongoing)|Saluda Medical: Uncompensated Consultant (Ongoing)|Saluda Medical: Stock Options (Ongoing
Michael Schatman, PhD | Speaker
Apurano Pharma: Consulting Fees (Ongoing)
Pedro Emanuel Rocha Flores, PhD | Oral Abstract Presenter
BackStop Neural Inc: *Employee/Executive (Ongoing)
Jason Pope, MD | Oral Abstract Presenter
Abbott: Consulting Fees (Ongoing)|Abbott: Contracted Research (Ongoing)|Aurora Spine: Consulting Fees (Ongoing)|Aurora Spine: Contracted Research (Ongoing)|Aurora Spine: Own Stock (Ongoing)|Aurora Spine: Royalty (Ongoing)|Biotronik: Consulting Fees (Ongoing)|Biotronik: Contracted Research (Ongoing)|Celeri Health: Own Stock (Ongoing)|Mainstay: Consulting Fees (Ongoing)|Mainstay: Contracted Research (Ongoing)|Painteq: Consulting Fees (Ongoing)|Painteq: Contracted Research (Ongoing)|Painteq: Own Stock (Ongoing)|Saluda: Consulting Fees (Ongoing)|Saluda: Contracted Research (Ongoing)|Saluda: Stock Options (Ongoing)|Spark: Consulting Fees (Ongoing)|Spark: Own Stock (Ongoing)|SPR: Consulting Fees (Ongoing)|SPR: Contracted Research (Ongoing)|SPR: Stock Options (Ongoing)|Vertos: Consulting Fees (Ongoing)|Vertos: Contracted Research (Ongoing)|Vertos: Own Stock (Ongoing)|WISE: Consulting Fees (Ongoing)
Agenda
Welcome
Ryan D'Souza, MD and Nasir Hussain, MD, MSc
Panel Discussion:
Robert Hurley, MD, PhD
Vision for future research in neuromodulation
Robert Levy, MD, PhD
Collaboration between journals on common goals that would advance the field (e.g. multi-society guidelines)
Michael Schatman, PhD
Preparation of an impactful manuscript
Ryan D'Souza, MD
Nasir Hussain, MD, MSc
Christopher Gilligan, MD
Oral Abstract Presentation: Human-Sized Softening Multi-Electrode Arrays for Optimized Spinal Cord Stimulation
Pedro Emanuel Rocha Flores, PhD
Oral Abstract Presentation: Evoked Compound Action Potentials Across Spinal Cord Injury and Chronic Pain
Disa Sullivan
Oral Abstract Presentation: Identifying SCS Trial Responders Immediately After Postoperative ECAP Dose-Controlled Closed-Loop Therapy Programming
Jason Pope, MD
Closing Discussion
Ryan D'Souza, MD and Nasir Hussain, MD, MSc
Refund Policy
Educational Programs (except the in-person Annual Meeting) – Fees for programs are non-refundable. For more information, please visit the NANS website for the full refund policy
Credit Statement
This is activity is not eligible for CME credit.